These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 18349088)

  • 1. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk.
    Bhattacharyya T; Nicholls SJ; Topol EJ; Zhang R; Yang X; Schmitt D; Fu X; Shao M; Brennan DM; Ellis SG; Brennan ML; Allayee H; Lusis AJ; Hazen SL
    JAMA; 2008 Mar; 299(11):1265-76. PubMed ID: 18349088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.
    Tang WH; Hartiala J; Fan Y; Wu Y; Stewart AF; Erdmann J; Kathiresan S; ; Roberts R; McPherson R; Allayee H; Hazen SL
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2803-12. PubMed ID: 22982463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement.
    Trenk D; Hochholzer W; Fromm MF; Zolk O; Valina CM; Stratz C; Neumann FJ
    Circ Cardiovasc Genet; 2011 Aug; 4(4):429-36. PubMed ID: 21685174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PON1 lactonase activity and its association with cardiovascular disease.
    Murillo-González FE; Ponce-Ruiz N; Rojas-García AE; Rothenberg SJ; Bernal-Hernández YY; Cerda-Flores RM; Mackness M; Barrón-Vivanco BS; González-Arias CA; Ponce-Gallegos J; Medina-Díaz IM
    Clin Chim Acta; 2020 Jan; 500():47-53. PubMed ID: 31626760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.
    Bortolasci CC; Vargas HO; Souza-Nogueira A; Gastaldello Moreira E; Vargas Nunes SO; Berk M; Dodd S; Barbosa DS; Maes M
    Redox Rep; 2014 Nov; 19(6):232-41. PubMed ID: 25037113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patients.
    Hulot JS; Collet JP; Cayla G; Silvain J; Allanic F; Bellemain-Appaix A; Scott SA; Montalescot G
    Circ Cardiovasc Interv; 2011 Oct; 4(5):422-8. PubMed ID: 21972404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder.
    Bortolasci CC; Vargas HO; Souza-Nogueira A; Barbosa DS; Moreira EG; Nunes SO; Berk M; Dodd S; Maes M
    J Affect Disord; 2014 Apr; 159():23-30. PubMed ID: 24679385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylesterase activity and antioxidant status depend on PON1-Q192R and PON1-L55M polymorphisms in subjects with increased risk of cardiovascular disease consuming walnut-enriched meat.
    Nus M; Frances F; Librelotto J; Canales A; Corella D; Sánchez-Montero JM; Sánchez-Muniz FJ
    J Nutr; 2007 Jul; 137(7):1783-8. PubMed ID: 17585031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
    Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
    Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis and arteriosclerosis parameters in stroke patients associate with paraoxonase polymorphism and esterase activities.
    Shenhar-Tsarfaty S; Waiskopf N; Ofek K; Shopin L; Usher S; Berliner S; Shapira I; Bornstein NM; Ritov Y; Soreq H; Ben Assayag E
    Eur J Neurol; 2013 Jun; 20(6):891-8. PubMed ID: 23305304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women.
    van Himbergen TM; van der Schouw YT; Voorbij HA; van Tits LJ; Stalenhoef AF; Peeters PH; Roest M
    Atherosclerosis; 2008 Aug; 199(2):408-14. PubMed ID: 18164014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Human Paraoxonase-1 Polymorphism (Q192R) on Serum Levels of Clinical Biomarkers Indicatives of Cardiovascular Diseases Risk in Mexican Women.
    Ochoa-Martínez ÁC; Orta-García ST; Varela-Silva JA; Pérez-Maldonado IN
    Biochem Genet; 2020 Oct; 58(5):801-820. PubMed ID: 32519276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients.
    Hasselwander O; Savage DA; McMaster D; Loughrey CM; McNamee PT; Middleton D; Nicholls DP; Maxwell AP; Young IS
    Kidney Int; 1999 Jul; 56(1):289-98. PubMed ID: 10411705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk.
    Mendonça MI; Dos Reis RP; Freitas AI; Pereira A; Sousa AC; Freitas S; Ornelas I; Freitas C; Brehm A; Araújo JJ
    Rev Port Cardiol; 2010 Apr; 29(4):571-80. PubMed ID: 20734577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of paraoxonase-1(Q192R and L55M) gene polymorphisms and activity with colorectal cancer and effect of surgical intervention.
    Ahmed NS; Shafik NM; Elraheem OA; Abou-Elnoeman SE
    Asian Pac J Cancer Prev; 2015; 16(2):803-9. PubMed ID: 25684529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.
    Birjmohun RS; Vergeer M; Stroes ES; Sandhu MS; Ricketts SL; Tanck MW; Wareham NJ; Jukema JW; Kastelein JJ; Khaw KT; Boekholdt SM
    PLoS One; 2009 Aug; 4(8):e6809. PubMed ID: 19710913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase-1 polymorphisms and cerebral ischemic stroke: a pilot study in mexican patients.
    Martínez-Salazar MF; Soriano-Martínez ML; Juantorena-Ugas A; Almenares-López D; Yescas P; Boll MC; Monroy-Noyola A
    Colomb Med (Cali); 2018 Sep; 49(3):223-227. PubMed ID: 30410197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 1 activities and genetic variation in childhood obesity.
    Rupérez AI; López-Guarnido O; Gil F; Olza J; Gil-Campos M; Leis R; Tojo R; Cañete R; Gil A; Aguilera CM
    Br J Nutr; 2013 Nov; 110(9):1639-47. PubMed ID: 23789921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.
    Bounafaa A; Berrougui H; Ghalim N; Nasser B; Bagri A; Moujahid A; Ikhlef S; Camponova P; Yamoul N; Simo OK; Essamadi A; Khalil A
    PLoS One; 2015; 10(8):e0133719. PubMed ID: 26241956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.